Hey lawman- been a while since I have seen one of your posts. IMO DMTK is either gonna get bot or their next 3-4 genomics are gonna start hitting. Either way a winner; with telemed driven by GP's/internists who no longer have to refer simple evaluations to derms and the derms getting the more acurate profitable real surgical referrals instead of looking at a bunch of non-issue suspects moles, its a winner.